TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,977 | -1.5% | 451 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,085 | -4.7% | 451 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,432 | +106071.4% | 451 | -4.9% | 0.00% | 0.0% |
| Q4 2022 | $7 | -99.9% | 474 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -14.3% | 474 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | +16.7% | 474 | +74.3% | 0.00% | -50.0% |
| Q3 2014 | $6,000 | +20.0% | 272 | +19.8% | 0.00% | 0.0% |
| Q2 2014 | $5,000 | 0.0% | 227 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $5,000 | 0.0% | 227 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,000 | -28.6% | 227 | -19.8% | 0.00% | -33.3% |
| Q3 2013 | $7,000 | +16.7% | 283 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $6,000 | 0.0% | 283 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $6,000 | – | 283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |